The FDA is reminding health care professionals of the risk of major birth defects (MBDs) in babies exposed to one of the few medications to be FDA approved for Migraine prevention during the mother's pregnancy.
Valproate sodium and related medications subject to this warning include:
- divalproex sodium: Depakote, Depakote CP, Depakote ER
- valproate sodium: Depacon
- valproic acid: Depakene and Stavzor
Women who take these medications during pregnancy have an increased risk of giving birth to...